CITIGROUP INC - SPRINGWORKS THERAPEUTICS INC ownership

SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 141 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of SPRINGWORKS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,837,162
-20.3%
79,462
-9.6%
0.00%
-50.0%
Q2 2023$2,305,263
-50.4%
87,920
-51.3%
0.00%
-33.3%
Q1 2023$4,644,577
+26.6%
180,442
+28.0%
0.00%0.0%
Q4 2022$3,667,774
-42.7%
141,014
-37.2%
0.00%
-40.0%
Q3 2022$6,403,000
+2.4%
224,430
-11.7%
0.01%0.0%
Q2 2022$6,255,000
+275.7%
254,062
+761.1%
0.01%
+400.0%
Q1 2022$1,665,000
-60.3%
29,504
-56.4%
0.00%
-50.0%
Q4 2021$4,197,000
+74.0%
67,718
+78.1%
0.00%
+100.0%
Q3 2021$2,412,000
-46.5%
38,026
-30.5%
0.00%
-66.7%
Q2 2021$4,512,000
+8.2%
54,746
-3.4%
0.00%0.0%
Q1 2021$4,171,000
+342.3%
56,688
+336.1%
0.00%
+200.0%
Q4 2020$943,000
+464.7%
12,998
+269.8%
0.00%
Q3 2020$167,000
-46.0%
3,515
-52.2%
0.00%
Q2 2020$309,000
+166.4%
7,360
+71.2%
0.00%
Q1 2020$116,000
+43.2%
4,298
+105.3%
0.00%
Q4 2019$81,0002,0940.00%
Other shareholders
SPRINGWORKS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 5,831,307$480,558,00031.49%
Consonance Capital Management LP 1,199,339$98,838,00011.90%
Boxer Capital, LLC 2,075,905$171,075,0006.04%
Perceptive Advisors 9,699,824$799,362,0005.19%
Orbimed Advisors 6,044,266$498,108,0005.04%
Samsara BioCapital, LLC 169,852$13,998,0001.73%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,375,775$113,378,0001.50%
SPHERA FUNDS MANAGEMENT LTD. 195,117$16,080,0001.09%
Artal Group S.A. 500,000$41,205,0000.84%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 558,574$46,032,0000.82%
View complete list of SPRINGWORKS THERAPEUTICS INC shareholders